Beasley Allen in the News

Articles 331 to 340 of 684 .

Jury to Resume Deliberations in Vioxx Case

| December 9, 2005
Jurors in the first federal trial over Vioxx were to resume deliberating about whether Merck & Co. was negligent in designing and marketing the once-popular painkiller and if it failed to warn about the drug's risks.

Medical Journal says Merck study Omitted key Data

| December 9, 2005
The New England Journal of Medicine said it has discovered that data about three Vioxx patients who suffered heart attacks were excised from a crucial study sponsored by Merck & Co., making the painkiller look safer than it should have.

Plaintiffs in Vioxx Case File Motion for Mistrial

| December 9, 2005
Attorneys for the plaintiff in a federal trial over Vioxx filed for a mistrial, citing data that was withheld from a Merck & Co. clinical study about the painkiller when it was submitted to the New England Journal of Medicine.

Jury Resumes Work in Vioxx Trial

The Associated Press | December 9, 2005
HOUSTON - Jurors in the first federal trial over Vioxx were to resume deliberating about whether Merck & Co. was negligent in designing and marketing the once-popular painkiller and if it failed to warn about the drug's risks.

Medical Journal Says Merck Study Omitted Key Data Allegation Could Damage Company in Vioxx Trials, Third Case Goes to Jury

The Wall Street Journal | December 9, 2005
The New England Journal of Medicine said it has discovered that data about three Vioxx patients who suffered heart attacks were excised from a crucial study sponsored by Merck & Co., making the painkiller look safer than it should have.

Jurors in Vioxx trial Deliberate two hours without Verdict

The Associated Press | December 8, 2005
Jurors deliberated about two hours Thursday without reaching a verdict in the first trial stemming from a federal lawsuit against Merck & Co. over its once-popular painkiller Vioxx.

Merck Accused of Putting Vioxx Profits Before Safety

Bloomberg | December 8, 2005
Dec. 8 (Bloomberg) -- Merck & Co. put profits ahead of consumers' safety by hiding heart risks of its Vioxx painkiller, a lawyer told a jury in closing arguments of the third trial of a lawsuit filed over the drug.

Federal Case on Merck's Vioxx Edges Toward Jury

Dow Jones Newswires | December 8, 2005
HOUSTON (Dow Jones) âe" The first federal trial on the risks of Merck & Co.âe(TM)s (MRK) Vioxx edged toward jury deliberations Thursday morning, with closing arguments from the two sides.

Jury begins deliberations in Vioxx case

The Houston Chronicle | December 8, 2005
Telling jurors their decision will have “far-reaching consequences for how drug companies conduct their business,” the attorney for a woman who believes her husband's short-term use of Vioxx caused his death asked the panel to send Merck a message.

Texas jury gets federal Merck Vioxx case

Reuters | December 8, 2005
The jury in the first federal case against drugmaker Merck & Co. Inc.'s Vioxx adjourned on Thursday after deliberating for about two hours over whether the painkiller contributed to a Florida man's death.